You searched for "regeneration"
Features of AMD treatment non-responders
1 October 2019
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a retrospective consecutive case series of 365 eyes with age-related macular degeneration (AMD) who had three monthly intravitreal aflibercept treatments for at least 12 months. Responders were defined as complete resolution of exudation, intraretinal oedema, subretinal fluid, pigment...
Age-related macular degeneration in elderly persons in Germany
1 April 2020
| Patty Mopamboli Mboli
|
EYE - Vitreo-Retinal
The authors present the findings of a cross-sectional study in 11 seniors’ community centres. Eleven community centres were screened with a total of 281 participants. A third of participants with gradable images were in normal retinal health (32%).The most common...
How accurate is the supplement content in both generic and branded ophthalmology supplements?
5 October 2020
| Tasmin Berman
|
EYE - Vitreo-Retinal
This prospective cross-section study compared the concentrations of Vitamin C, Vitamin E, Zinc, and Copper in five dietary supplements including both national and regional brands used for macular degeneration in the United States. They performed a comparative analysis using gas...
Characteristics of Charles Bonnet syndrome in patients with neovascular AMD
7 April 2021
| Ed Rule
|
EYE - Vitreo-Retinal
|
Age-related macular degeneration, Charles Bonnet syndrome, Low vision, Negative outcome, Visual hallucinations
This retrospective cross-sectional study aimed to characterise various aspects of Charles Bonnet syndrome hallucinations among patients with neovascular age-related macular degeneration (AMD). Five hundred and ten consecutive patients were asked a screening question to determine if they had ever suffered...
Effect of blue-light filtering intraocular lenses on age-related macular degeneration
7 April 2021
| Anna Song
|
EYE - Vitreo-Retinal
This is a retrospective cohort study evaluating whether blue-light filtering (BLF) intraocular lenses (IOL) offer prophylaxis for neovascular age-related macular degeneration (nAMD). The study included 11,397 eyes of 11,397 patients with a mean age of 75.4 ±8.3 years that underwent...
Macular pigment in relatives of AMD patients
3 April 2024
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
Blue light causes photo-oxidative retinal injury and macular pigment (MP), with lutein, zeaxanthin and mesozeaxanthin as the main components, as a filter that protects the macula from this damage. Previous studies indicated that low levels of macular pigment optical density...
Transsynaptic retrograde degeneration linked to homonymous visual field loss after stroke
10 May 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
centre, of individuals identified with homonymous visual field loss post ischaemic stroke. Exclusion criteria were bilateral ischaemia, anterior / pregeniculate visual pathway affected and other pathology with the potential to effect visual fields. The following were extracted from the medical...
Evisceration in India: demographic and clinical trends from a large multicentre cohort study
4 October 2023
| Su Young
|
EYE - Orbit
In this multicentre cohort study, the authors investigated a total of 2071 patients who underwent evisceration with primary implant placement over a six-year period at four tertiary eyecare centres in India. Out of 1,345,480 new ophthalmic presentations during the study...
Sustainability in eyecare: Intraocular gases and the climate emergency
In 2020 the NHS became the first national health system to commit to delivering ‘net zero’ carbon emissions by 2040. The author investigates how the impact of ophthalmic surgery can be reduced. Medical gases have been used in ophthalmic surgery...425,000 NHS patients use online GP registration service in first year
25 August 2023
|
NHS, services, digital services, online, patient journey, register with a gp service
More than 425,000 patients have used a new national online service to register with a GP in its first year.
Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies
1 October 2018
| Rod McNeil
|
EYE - General
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
